John E. Bournas is currently the President & CEO of the International Society for Pharmaceutical Engineering (ISPE), based in Washington, DC. In this capacity, he is responsible for developing the 18,500 strong Society’s global initiatives and business operations that include leveraging technology to extend the reach of ISPE’s Membership, educational and training programs, among others. Mr. Bournas leads the organizational efforts in solidifying working relationships with international regulators and spearheads important global initiatives such as the Drug Shortages Prevention Plan and Quality Metrics, among others.
Prior to this role, Mr. Bournas, was the CEO and Executive Director of the World Federation of Hemophilia (WFH), an international patient-focused healthcare association, headquartered in Montreal, Canada. The WFH is comprised of 127 country-based societies and is officially recognized by the WHO.
Mr. Bournas was also a Senior Director of International Affairs at the American College of Cardiology (ACC), the largest global professional society for cardiologists. In this role, he traveled extensively in Asia, liaising closely with regional chapters and assisting in the development of local content and trainings. He has also worked in the pharmaceutical industry, having been a Senior Director at Cardinal Health and was involved in foreign affairs earlier in his career.
Mr. Bournas has a B.A in International Affairs, an M.A in Political Science from Fordham University in New York and an MBA from Macquarie University of Sydney, Australia.
He is completely fluent in English and Spanish. He is also proficient in French and Portuguese, as well as having comprehension of Greek and Japanese.
Mr. Bournas is married, with four children and currently resides in the Washington DC area.